PTEN and cancer: Little-known, in contrast, is its dual-specificity protein phosphatase activity against phosphotyrosine (pTyr), phosphoserine (pSer) and phosphothreonine (pThr), which was discovered and characterized [14] shortly after the identification of PTEN as one of the most frequently mutated tumor suppressor genes in human cancers.